CrushSCI.com
154.9Average days
172Median days
66Fastest days
235Longest days
702025 publications

Paper Review Records

All Paper Review Records

11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

78 days

Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE

Authors
Maéva Zysman; Ilyes Benlala; Alexandra Langlais; Laurent Greillier; Céline Mascaux; Francois Pinquie; Delphine Carmier; Lionel Moreau; Benoit Roch; Didier Debieuvre; Xavier Dhalluin; Etienne Giroux-Leprieur; Elodie Berton; Michael Duruisseaux; Judith Raimbourg; Audrey Rabeau; Adrien Dixmier; Charles Naltet; Virginie Westeel; Gérard Zalcman; Gael Dournes; Valérie GounantShow moreShow less
Affiliations
Service des maladies respiratoires - CHU Haut-Lévèque - 33600 Pessac – 74704 Centre de Recherche Cardio-Thoracique de Bordeaux - Unité INSERM 1045medicine, Bordeaux hospital centre, 33604 Pessac; INSERM U1045, CIC 1401, Bordeaux France; Service d'imagerie Cardiaque et Thoracique - CHU de Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux - INSERM U1045, Bordeaux France; Intergroupe Francophone de Cancérologie Thoracique (IFCT) Paris France; Service d'Oncologie Multidisciplinaire & Innovations Thérapeutiques, Assistance Publique – Hôpitaux de Marseille, Aix Marseille Univ Marseille France; Service de Pneumologie - Pôle de Pathologie Thoracique, Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg France; Service de Pneumologie, Centre Hospitalier Général Le Mans France; Service de Pneumologie, CHU Bretonneau Tours France; Service de Médecine F, Hôpital Louis Pasteur Colmar France; Equipe Pneumologie et Oncologie, Service de Pneumologie, Allergologie et Oncologie Thoracique, CHU Montpellier - Université de Montpellier - INSERM U1194 Montpellier France; Service de Pneumologie, Groupe Hospitalier Région Mulhouse et Sud-Alsace Mulhouse France; Service Pneumologie et Oncologie Thoracique, Institut Cœur Poumon Lille France; Service de Pneumologie et Oncologie Thoracique, Hôpital APHP Ambroise Paré Boulogne France; Service de Pneumologie, CHU Grenoble France; Service de Pneumologie - Lyon Pradel, Hôpital Cardio-Vasculaire & Pneumologique L Pradel - Bron France; Institut de Cancérologie de l’Ouest, F-44805 Saint Herblain France; Service de Pneumologie, CHU de Toulouse France; Service de Pneumologie, Centre Hospitalier Universitaire - Hôpital de la Source Orleans France; Service de Pneumologie Oncologie, Groupe Hospitalier Paris Saint Joseph Paris France; Service de Pneumologie, Université Marie et Louis Pasteur, CHU Besançon, EFS, INSERM, UMR RIGHT, Besancon France; Université Paris Cité, Service d’Oncologie Thoracique, CIC INSERM 1425, Hôpital Bichat Claude Bernard, AP-HP. Nord - Paris FranceShow moreShow less
Source PDF DOI Publisher page
235 days

External validation of the CAPAD score to predict the occurrence of clinically significant pneumothorax after CT-guided percutaneous transthoracic lung biopsy

Authors
Guillaume Eberst; Waqaas Mohammad; Alicia Guillien; Antoine Khalil; Joffrey Hamam; Julien Behr; Philippe Manzoni; Paul Calame; Franck Grillet; Gérard Zalcman; Valérie Gounant; Virginie WesteelShow moreShow less
Affiliations
Chest Disease Department, University Hospital, Besançon, France; Methodology and Quality of Life in Oncology Unit, University Hospital, Besançon, France; Marie et Louis Pasteur University, EFS, INSERM, UMR RIGHT, F-25000, Besançon, France; Department of Radiology, Groupe Hospitalier Bichat–Claude-Bernard, Assistance publique–Hôpitaux de Paris, 75018, Paris, France; University of Grenoble Alpes, French National Institute of Health and Medical Research, French National Center for Scientific Research, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences, Grenoble, France; Department of Radiology, University Hospital of Besançon, Besançon, France; Université Paris Cité, Department of Thoracic Oncology, CIC INSERM 1425, Groupe Hospitalier Bichat–Claude-Bernard, Assistance publique–Hôpitaux de Paris, 75018, Paris, FranceShow moreShow less
Source PDF DOI Publisher page
128 days

Diffuse alveolar hemorrhage in primary antiphospholipid syndrome: A case series of six patients

Authors
Martina Doubková; Marianna Štefániková; Alena Buliková; Terezie Ivaničová; Michael DoubekShow moreShow less
Affiliations
Department of Pulmonary Diseases and Tuberculosis, Faculty of Medicine, Masaryk University and University Hospital Brno, 625 00, Brno, Czechia; Department of Internal Medicine – Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, ERN EuroBloodNet Centre, Brno, CzechiaShow moreShow less
Source PDF DOI Publisher page
212 days

Diaphragm dysfunction in mechanically ventilated patients: Comparing volume and pressure modes

Authors
Golnar Sabetian; Seyed Mohammad Nasirodin Tabatabaei; Vida Naderi boldaji; Farid Zand; Mansoor Masjedi; Reza Nikandish; Mahsa BanifatemiShow moreShow less
Affiliations
Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Anesthesiology and Critical Care Department, Zahedan University of Medical Sciences, Zahedan, IranShow moreShow less
Source PDF DOI Publisher page
172 days

Efficacy and safety of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension associated with sickle cell disease

Authors
Mitja Jevnikar; Sarah Macisaac; Philippe Brenot; François Lionnet; Aline Santin; Anne Roche; Christelle Chantalat-Auger; Yoichi Sugiyama; Thomas d'Humières; Athénaïs Boucly; Olivier Sitbon; David Montani; Olaf Mercier; Samuel Dolidon; Jean-Noel Andarelli; Pablo Bartolucci; Elie Fadel; Marc Humbert; Xavier Jais; Laurent SavaleShow moreShow less
Affiliations
INSERM UMR_S 999 « Pulmonary Hypertension: Pathophysiology and Novel Therapies », Hôpital Marie Lannelongue, 92350, Le Plessis-Robinson, France; Université Paris-Saclay, Faculté de Médecine, 94276, Le Kremlin-Bicêtre, France; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France; Department of Medicine, McMaster University Hamilton, Canada; Department of Radiology, Hôpital Marie Lannelongue, Le Plessis-Robinson, France; Department of Internal Medicine, Tenon Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris (AP-HP), Service de médecine interne, Hôpital Bicêtre, 94270, Le Kremlin-Bicêtre, France; Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan; Department of Physiology, FHU SENCODE, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, INSERM IMRB U955, Université Paris Est, Créteil, France; Department of Thoracic and Vascular Surgery and Heart-lung Transplantation, Marie Lannelongue Hospital, Le Plessis Robinson, France; Sickle Cell Referral Center - UMGGR, Plateforme d'expertise Maladies Rares Grand Paris Est, UPEC, FHU SENEC, CHU Henri Mondor APHP, Créteil, France; Department of Internal Medicine, Henri-Mondor University Hospital-UPEC/Assistance Publique-Hôpitaux de Paris, Créteil, FranceShow moreShow less
Source PDF DOI Publisher page
210 days

Impact of season and geography on COPDCompEx: a composite endpoint for COPD trials

Authors
Enti Spata; Alexandra Jauhiainen; Carla A. Da SilvaShow moreShow less
Affiliations
R&I Biometrics and Statistical Innovation, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; R&I Biometrics and Statistical Innovation, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Early Respiratory and Immunology Clinical Development, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SwedenShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Respiratory Medicine and Research take to review a manuscript?

As of 2026-11-19, CrushSCI has 11 complete review records for Respiratory Medicine and Research. The fastest paper went from submission to acceptance in 66 days (Current practices, barriers, and unmet needs in intensive care unit bronchoscopy: Results of an international survey, received 2026-04-22, accepted 2026-06-27); the slowest took 235 days. The average is 154.9 days and the median is 172 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.